Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of the Opiate Antagonist Naltrexone on the Emotional Valence of Dreams

NCT02792140 is registered in ClinicalTrials.gov with University of Bern as lead sponsor.

NCT NCT02792140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02792140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of the Opiate Antagonist Naltrexone on the Emotional Valence of Dreams
Lead sponsor
University of Bern
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2016
Completion date
November 30, 2016
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuroscience of dreaming, healthy